Probiotic kefir consumption improves serum apolipoprotein A1 levels in metabolic syndrome patients: a randomized controlled clinical trial.

Bellikci-Koyu, Ezgi; Sarer-Yurekli, Banu Pinar; Karagozlu, Cem; Aydin-Kose, Fadime; Ozgen, Ahmet Gokhan; Buyuktuncer, Zehra

Bellikci-Koyu, Ezgi; Sarer-Yurekli, Banu Pinar; Karagozlu, Cem; Aydin-Kose, Fadime; Ozgen, Ahmet Gokhan; Buyuktuncer, Zehra.

Afiliação

Bellikci-Koyu E; Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey; Department of Nutrition and Dietetics, Faculty of Health Sciences, Izmir Katip Celebi University, Izmir, Turkey.
Sarer-Yurekli BP; Department of Endocrinology, Faculty of Medicine, Ege University, Izmir, Turkey.
Karagozlu C; Department of Dairy Technology, Faculty of Agriculture, Ege University, Izmir, Turkey.
Aydin-Kose F; Department of Biochemistry, Faculty of Pharmacy, Izmir Katip Celebi University, Izmir, Turkey.
Ozgen AG; Department of Endocrinology, Faculty of Medicine, Ege University, Izmir, Turkey.
Buyuktuncer Z; Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey. Electronic address: zbtuncer@hacettepe.edu.tr.

Nutr Res ; 102: 59-70, 2022 06.

Article em En | MEDLINE | ID: mdl-35405603

Assuntos

Kefir; Síndrome Metabólica; Probióticos; Animais; Apolipoproteína A-I; LDL-Colesterol; Humanos; Leite

Palavras-chave

Diabetes; Glycemic control; Hyperlipidemia; Hypertension; Kefir; Probiotic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Probióticos / Síndrome Metabólica / Kefir Tipo de estudo: Clinical_trials Limite: Animals / Humans Idioma: En Revista: Nutr Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google